[Acceptance of the disease in patients with lung cancer]. / Akceptacja choroby przez chorych na nowotwór pluca.

UNLABELLED: Lung cancer is the most common malignancy in men and the second frequent in women. Cancer is not without consequences on the life and functioning of a patient. The process of adopting the disease is based on restoring the patient's psychological balance, reduction of the emotional discomfort and self-confidence. AIM: The aim of the study was to assess the acceptance of lung cancer in patients with this diagnosis. MATERIALS AND METHODS: The study included 73 patients treated at the Pulmonology Ward of Podkarpackie Center for Lung Diseases, Department of Clinical Oncology of Podkarpackie Oncology Centre in Rzeszów and at the Department of Chemotherapy, Radiotherapy and Oncological Surgery of Podkarpackie Oncological Center in Brzozów. Author's questionnaire and Acceptance of Illness Scale (AIS) were used in the study. RESULTS: At the time of diagnosis 60.27% of the subjects accepted the disease, while at the time of the study 90.41% reconciled with the cancer diagnosis. The average degree of acceptance was found in 56.16% of the subjects. The respondents up to 60 years of age were characterized by a higher level of acceptance than patients over 60. The effect of age on the degree of being needed was observed, where higher average value was found in people up to 60 (p <0.05). It was demonstrated that age (up to 60) and the time elapsed since the diagnosis (up to 6 months) is significantly associated with less dependence on the others (p <0.05). CONCLUSIONS: The time elapsed since the diagnosis led to the increased in the acceptance of the disease. The age up to 60 was characterized by higher level of acceptance and a higher degree of being needed.

A Rare Case of Breast Malignant Phyllodes Tumor With Metastases to the Kidney: Case Report.

Phyllodes tumors are rare breast neoplasms. Surgery is the treatment of choice. The role of postoperative radiotherapy and chemotherapy is still under dispute, as there are no equivocal prognostic factors. Treatment failure results in the occurrence of distant metastasis-mainly to the lungs, bones, liver, and brain. We have described the case of a woman with a malignant phyllodes tumor of the breast that was surgically treated. She did not receive adjuvant therapy because there is no consensus on the role of postoperative chemotherapy and radiotherapy. One year following the surgery, the patient had left-sided nephrectomy performed because of a rapidly growing tumor of the kidney. Renal cancer was suspected; however, a histopathological examination revealed that it was a metastatic phyllodes tumor. At the same time, the patient was diagnosed as having metastases in the other kidney, the lungs, liver, and bones.Our case report describes not only an unusual localization of the metastases (in the kidneys), but also failure of the chemotherapy and the aggressive course of malignant phyllodes tumor. Identification of patients with high risk for distant metastasis and the introduction of uniform rules for the management of adjuvant chemotherapy and radiotherapy would make planning treatment as efficacious as possible.

[Hyponatremia in the course of small cell lung cancer--a case report]. / Hiponatremia w przebiegu drobnokomórkowego raka pluca--opis przypadku.

Hyponatremia is a common electrolyte disorder occurring in patients with malignancy. Typically, it runs in the form of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Among malignant diseases it is often ascertained from small cell lung cancer. In the form of paraneoplastic syndrome it may precede clinical and radiological symptoms malignant disease. Hyponatremia requires special attention because of the neurological consequences and the risk of death. We present a case of a patient in whom the occurrence of hyponatremia preceded the appearance of clinical symptoms of lung cancer and has been the reason to start the diagnosis. The normalization of serum sodium was the first signal response to chemotherapy. In contrast, a statement confirmed the recurrence of hyponatremia progression of the disease in the form of metastases to the central nervous system. Speeches hyponatremia refractory symptomatic treatment should be a cause of further investigation into the neoplastic process. Recurrent hyponatremia during or after treatment may suggest its progression. Therefore, monitoring the sodium level is required not only during treatment, but also after the oncological treatment.